Here are the drugs and financial support services available to patients receiving treatment for Gastric/Gastroesophageal Junction Cancer.
FDA Approvals, News & UpdatesGastric Cancer
In February 2019, the FDA approved Lonsurf for the treatment of patients with metastatic gastric (stomach) cancer or gastroesophageal junction adenocarcinoma. This drug was previously approved only for patients with metastatic colorectal cancer.
Gastric CancerPatient Stories
Cathy Sherman Freeman’s father, who was Head of Publications at Walt Disney Studios, passed away of gastrointestinal stromal tumor (GIST), the same rare cancer she was diagnosed with several years ago.
Results 1 - 5 of 5